(Q48601558)

13 February 2018

title

Penetration of etoposide into human malignant brain tumors after intravenous and oral administration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

1 reference

1 reference

1 reference

2 December 2023

1 reference

2 December 2023

author name string

K. Kiya

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

T. Uozumi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

H. Ogasawara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

K. Sugiyama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

T. Hotta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

T. Mikami

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

K. Kurisu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312906

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1312906

12 September 2022

publication date

1 January 1992

1 reference

13 February 2018

full work available at URL

http://link.springer.com/content/pdf/10.1007/BF00686001.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00686001/fulltext.html

2 December 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00686001

2 December 2023

1 reference

Cancer Chemotherapy and Pharmacology

2 December 2023

published in

1 reference

13 February 2018

volume

29

1 reference

13 February 2018

page(s)

339-342

1 reference

13 February 2018

issue

5

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/bf00686001

exact match

0 references

cites work

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00686001

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

21 January 2018

1 reference

12 December 2020

High-dose etoposide in the treatment of relapsed primary brain tumors.

1 reference

12 December 2020

Single-agent oral etoposide for elderly small cell lung cancer patients.

1 reference

12 December 2020

Treatment of brain metastases of lung cancer with high doses of etoposide (VP16–213). Cooperative study from the groupe français pneumo-cancérologie

1 reference

12 December 2020

Intracarotid VP-16 in malignant brain tumors.

1 reference

12 December 2020

The clinical pharmacology of VM26 and VP16-213. A brief overview

1 reference

12 December 2020

Pharmacokinetics of high dose etoposide (VP 16-213)

1 reference

12 December 2020

Primary chemotherapy of brain metastasis in small-cell lung cancer

1 reference

12 December 2020

Chronic daily administration of oral etoposide--a phase I trial

1 reference

12 December 2020

Penetration of VP-16 (etoposide) into human intracerebral and extracerebral tumors.

1 reference

12 December 2020

Pharmacokinetics of etoposide in gestochoriocarcinoma

1 reference

12 December 2020

A case report of advanced malignant mixed germ cell tumor of parasellar origin indicating marked efficacy of a salvage combined chemotherapy of CDDP and etoposide and subsequent chemotherapy using oral etoposide

1 reference

12 December 2020

[Serum and cerebrospinal fluid levels after high dose of etoposide administrated intravenously]

1 reference

12 December 2020

Phase II treatment of central nervous system gliomas with high-dose etoposide and autologous bone marrow transplantation.

1 reference

12 December 2020

Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patients

1 reference

12 December 2020

Oral etoposide therapy in stage III-IV ovarian carcinoma

1 reference

12 December 2020

Brain metastases of lung cancer: excessive toxicity of high dose VP 16 213

1 reference

12 December 2020

Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. An experimental and clinical study

1 reference

12 December 2020

The clinical pharmacology of etoposide

1 reference

12 December 2020

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration

1 reference

12 December 2020

Podophyllotoxins for brain metastases of small cell lung cancer

1 reference

12 December 2020

Cancer Treatment Reports

3

69

69

M D'Incalci

1985

1 reference

2 December 2023

Cancer Treatment Reports

5

69

603

GP Finn

1985

1 reference

2 December 2023

Cancer Treatment Reports

6

71

759

L Giannone

1987

1 reference

2 December 2023

11

23

479

G Idzu

1989

1 reference

Proceedings of the American Association for Cancer Research

2 December 2023

20

24

133

DJ Stewart

1983

1 reference

2 December 2023

Identifiers

DOI

10.1007/BF00686001

1 reference

13 February 2018

1 reference

13 February 2018